Seikrit, Claudia
Schimpf, Judith I.
Wied, Stephanie
Stamellou, Eleni
Izcue, Ana
Pabst, Oliver
Rauen, Thomas
Lenaerts, Kaatje
Floege, Jürgen
Clinical trials referenced in this document:
Documents that mention this clinical trial
Intestinal permeability in patients with IgA nephropathy and other glomerular diseases: an observational study
https://doi.org/10.1007/s40620-022-01454-2
Funding for this research was provided by:
Dr. Werner Jackstädt-Stiftung
RWTH Aachen University
Article History
Received: 2 March 2022
Accepted: 23 August 2022
First Online: 15 September 2022
Declarations
:
: J.F. has received consultant honoraria from Omeros and Retrophin, USA, and Calliditas, Sweden. C.S. has been supported by a clinician scientist-program of the Faculty of Medicine of the RWTH Aachen University. E.S. is supported by the clinical research unit InteraKD consortium CRU5011 (SP03) by the German Research Foundation (DFG), a START grant (19/21 to E.S.) and by a clinician scientist-program of the Faculty of Medicine of the RWTH Aachen University. E.S. has received a research grant of the German Society of Nephrology (DGfN). The other authors have no relevant financial or non-financial interests to disclose.
: The study was approved by the by the local ethics committee (EK 238/16) and has been performed in accordance with the 1964 Helsinki Declaration.
: Informed consent was obtained from all individual participants prior to their enrollment in the study.